269 related articles for article (PubMed ID: 30096879)
1. Sanger and Next Generation Sequencing Approaches to Evaluate HIV-1 Virus in Blood Compartments.
Arias A; López P; Sánchez R; Yamamura Y; Rivera-Amill V
Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30096879
[TBL] [Abstract][Full Text] [Related]
2. RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients.
Alidjinou EK; Deldalle J; Hallaert C; Robineau O; Ajana F; Choisy P; Hober D; Bocket L
J Antimicrob Chemother; 2017 Oct; 72(10):2823-2830. PubMed ID: 29091197
[TBL] [Abstract][Full Text] [Related]
3. Comparison of an
Tzou PL; Ariyaratne P; Varghese V; Lee C; Rakhmanaliev E; Villy C; Yee M; Tan K; Michel G; Pinsky BA; Shafer RW
J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618499
[TBL] [Abstract][Full Text] [Related]
4. Limited Marginal Utility of Deep Sequencing for HIV Drug Resistance Testing in the Age of Integrase Inhibitors.
Dalmat RR; Makhsous N; Pepper GG; Magaret A; Jerome KR; Wald A; Greninger AL
J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30305383
[TBL] [Abstract][Full Text] [Related]
5. Routine drug resistance testing in HIV-1 proviral DNA, using an automated next- generation sequencing assay.
Alidjinou EK; Coulon P; Hallaert C; Robineau O; Meybeck A; Huleux T; Ajana F; Hober D; Bocket L
J Clin Virol; 2019 Dec; 121():104207. PubMed ID: 31707202
[TBL] [Abstract][Full Text] [Related]
6. Next generation sequencing improves detection of drug resistance mutations in infants after PMTCT failure.
Fisher RG; Smith DM; Murrell B; Slabbert R; Kirby BM; Edson C; Cotton MF; Haubrich RH; Kosakovsky Pond SL; Van Zyl GU
J Clin Virol; 2015 Jan; 62():48-53. PubMed ID: 25542470
[TBL] [Abstract][Full Text] [Related]
7. Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive Patients.
Nanfack AJ; Redd AD; Bimela JS; Ncham G; Achem E; Banin AN; Kirkpatrick AR; Porcella SF; Agyingi LA; Meli J; Colizzi V; Nádas A; Gorny MK; Nyambi PN; Quinn TC; Duerr R
J Clin Microbiol; 2017 Sep; 55(9):2785-2800. PubMed ID: 28659324
[TBL] [Abstract][Full Text] [Related]
8. Prospective Evaluation of the Vela Diagnostics Next-Generation Sequencing Platform for HIV-1 Genotypic Resistance Testing.
Weber J; Volkova I; Sahoo MK; Tzou PL; Shafer RW; Pinsky BA
J Mol Diagn; 2019 Nov; 21(6):961-970. PubMed ID: 31382033
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 Drug Resistance Assay Using Ion Torrent Next Generation Sequencing and On-Instrument End-to-End Analysis Software.
Pyne MT; Simmon KE; Mallory MA; Hymas WC; Stevenson J; Barker AP; Hillyard DR
J Clin Microbiol; 2022 Jul; 60(7):e0025322. PubMed ID: 35699434
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Automatic Analysis of Ultradeep Pyrosequencing Raw Data to Determine Percentages of HIV Resistance Mutations in Patients Followed-Up in Hospital.
Bellecave P; Recordon-Pinson P; Fleury H
AIDS Res Hum Retroviruses; 2016 Jan; 32(1):85-92. PubMed ID: 26529549
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Vela Diagnostics HIV-1 genotyping assay on an automated next generation sequencing platform.
May S; Adamska E; Tang J
J Clin Virol; 2020 Jun; 127():104376. PubMed ID: 32344322
[TBL] [Abstract][Full Text] [Related]
12. New Aspects of the Virus Life Cycle and Clinical Utility of Next Generation Sequencing based HIV-1 Resistance Testing in the Genomic, the Proviral, and the Viral Reservoir of Peripheral Blood Mononuclear Cells.
Pröll J; Paar C; Taylor N; Skocic M; Freystetter A; Blaimschein A; Mayr R; Niklas N; Atzmüller S; Raml E; Wechselberger C
Curr HIV Res; 2022; 20(3):213-221. PubMed ID: 35331114
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 DNA ultra-deep sequencing analysis at initiation of the dual therapy dolutegravir + lamivudine in the maintenance DOLULAM pilot study.
Charpentier C; Montes B; Perrier M; Meftah N; Reynes J
J Antimicrob Chemother; 2017 Oct; 72(10):2831-2836. PubMed ID: 29091218
[TBL] [Abstract][Full Text] [Related]
14. A MiSeq-HyDRA platform for enhanced HIV drug resistance genotyping and surveillance.
Taylor T; Lee ER; Nykoluk M; Enns E; Liang B; Capina R; Gauthier MK; Domselaar GV; Sandstrom P; Brooks J; Ji H
Sci Rep; 2019 Jun; 9(1):8970. PubMed ID: 31222149
[TBL] [Abstract][Full Text] [Related]
15. Amino Acid Prevalence of HIV-1
Tzou PL; Rhee SY; Shafer RW
AIDS Res Hum Retroviruses; 2019 Oct; 35(10):924-929. PubMed ID: 31317771
[TBL] [Abstract][Full Text] [Related]
16. Shall I trust the report? Variable performance of Sanger sequencing revealed by deep sequencing on HIV drug resistance mutation detection.
Chen NY; Kao SW; Liu ZH; Wu TS; Tsai CL; Lin HH; Wong WW; Chang YY; Chen SS; Ku SW
Int J Infect Dis; 2020 Apr; 93():182-191. PubMed ID: 32061862
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 genotypic resistance testing using the Vela automated next-generation sequencing platform.
Raymond S; Nicot F; Carcenac R; Lefebvre C; Jeanne N; Saune K; Delobel P; Izopet J
J Antimicrob Chemother; 2018 May; 73(5):1152-1157. PubMed ID: 29444253
[TBL] [Abstract][Full Text] [Related]
18. Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq.
Dudley DM; Bailey AL; Mehta SH; Hughes AL; Kirk GD; Westergaard RP; O'Connor DH
Retrovirology; 2014 Dec; 11():122. PubMed ID: 25533166
[TBL] [Abstract][Full Text] [Related]
19. Detection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected Individuals.
Lee Z; Nishikawa S; Gao S; Eksteen JB; Czub M; Gill MJ; Osiowy C; van der Meer F; van Marle G; Coffin CS
PLoS One; 2015; 10(9):e0137568. PubMed ID: 26390290
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 Protease, Reverse Transcriptase, and Integrase Variation.
Rhee SY; Sankaran K; Varghese V; Winters MA; Hurt CB; Eron JJ; Parkin N; Holmes SP; Holodniy M; Shafer RW
J Virol; 2016 Jul; 90(13):6058-6070. PubMed ID: 27099321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]